These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31757767)

  • 41. Novel Epitopes of the Influenza Virus N1 Neuraminidase Targeted by Human Monoclonal Antibodies.
    Kirkpatrick Roubidoux E; Sano K; McMahon M; Carreño JM; Capuano C; Jiang K; Simon V; van Bakel H; Wilson P; Krammer F
    J Virol; 2022 May; 96(9):e0033222. PubMed ID: 35446141
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cross-reactive mouse monoclonal antibodies raised against the hemagglutinin of A/Shanghai/1/2013 (H7N9) protect against novel H7 virus isolates in the mouse model.
    Stadlbauer D; Amanat F; Strohmeier S; Nachbagauer R; Krammer F
    Emerg Microbes Infect; 2018 Jun; 7(1):110. PubMed ID: 29925896
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An epidemiologically significant epitope of a 1998 human influenza virus neuraminidase forms a highly hydrated interface in the NA-antibody complex.
    Venkatramani L; Bochkareva E; Lee JT; Gulati U; Graeme Laver W; Bochkarev A; Air GM
    J Mol Biol; 2006 Feb; 356(3):651-63. PubMed ID: 16384583
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Universal anti-neuraminidase antibody inhibiting all influenza A subtypes.
    Doyle TM; Hashem AM; Li C; Van Domselaar G; Larocque L; Wang J; Smith D; Cyr T; Farnsworth A; He R; Hurt AC; Brown EG; Li X
    Antiviral Res; 2013 Nov; 100(2):567-74. PubMed ID: 24091204
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mutations in Influenza A Virus Neuraminidase and Hemagglutinin Confer Resistance against a Broadly Neutralizing Hemagglutinin Stem Antibody.
    Prachanronarong KL; Canale AS; Liu P; Somasundaran M; Hou S; Poh YP; Han T; Zhu Q; Renzette N; Zeldovich KB; Kowalik TF; Kurt-Yilmaz N; Jensen JD; Bolon DNA; Marasco WA; Finberg RW; Schiffer CA; Wang JP
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30381484
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of the Immune Responses to and Cross-Protective Efficacy of Eurasian H7 Avian Influenza Viruses.
    Kwon HI; Kim YI; Park SJ; Song MS; Kim EH; Kim SM; Si YJ; Lee IW; Song BM; Lee YJ; Yun SJ; Kim WJ; Choi YK
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331080
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An influenza N1 neuraminidase-specific monoclonal antibody with broad neuraminidase inhibition activity against H5N1 HPAI viruses.
    Shoji Y; Chichester JA; Palmer GA; Farrance CE; Stevens R; Stewart M; Goldschmidt L; Deyde V; Gubareva L; Klimov A; Mett V; Yusibov V
    Hum Vaccin; 2011; 7 Suppl():199-204. PubMed ID: 21922687
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mutation of the Second Sialic Acid-Binding Site, Resulting in Reduced Neuraminidase Activity, Preceded the Emergence of H7N9 Influenza A Virus.
    Dai M; McBride R; Dortmans JCFM; Peng W; Bakkers MJG; de Groot RJ; van Kuppeveld FJM; Paulson JC; de Vries E; de Haan CAM
    J Virol; 2017 May; 91(9):. PubMed ID: 28202753
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development and characterization of an antibody that recognizes influenza virus N1 neuraminidases.
    Chen N; Wang R; Zhu W; Hao X; Wang J; Chen G; Qiao C; Li X; Liu C; Shen B; Feng J; Chai L; Yu Z; Xiao H
    PLoS One; 2024; 19(5):e0302865. PubMed ID: 38723016
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-neuraminidase immunity in the combat against influenza.
    Zhang X; Ross TM
    Expert Rev Vaccines; 2024; 23(1):474-484. PubMed ID: 38632930
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A neuraminidase activity-based microneutralization assay for evaluating antibody responses to influenza H5 and H7 vaccines.
    Zhao H; Xu K; Jiang Z; Shao M; Liu S; Li X; Wang J; Li C
    PLoS One; 2018; 13(11):e0207431. PubMed ID: 30440054
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of HA and NA glycosylation pattern changes on the transmission of avian influenza A(H7N9) virus in guinea pigs.
    Park S; Lee I; Kim JI; Bae JY; Yoo K; Kim J; Nam M; Park M; Yun SH; Cho WI; Kim YS; Ko YY; Park MS
    Biochem Biophys Res Commun; 2016 Oct; 479(2):192-197. PubMed ID: 27613087
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neuraminidase, the Forgotten Surface Antigen, Emerges as an Influenza Vaccine Target for Broadened Protection.
    Eichelberger MC; Monto AS
    J Infect Dis; 2019 Apr; 219(Suppl_1):S75-S80. PubMed ID: 30715357
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Broadly protective human antibodies that target the active site of influenza virus neuraminidase.
    Stadlbauer D; Zhu X; McMahon M; Turner JS; Wohlbold TJ; Schmitz AJ; Strohmeier S; Yu W; Nachbagauer R; Mudd PA; Wilson IA; Ellebedy AH; Krammer F
    Science; 2019 Oct; 366(6464):499-504. PubMed ID: 31649200
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interaction between a 1998 human influenza virus N2 neuraminidase and monoclonal antibody Mem5.
    Lee JT; Air GM
    Virology; 2006 Feb; 345(2):424-33. PubMed ID: 16297424
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recombinant virus-like particles elicit protective immunity against avian influenza A(H7N9) virus infection in ferrets.
    Liu YV; Massare MJ; Pearce MB; Sun X; Belser JA; Maines TR; Creager HM; Glenn GM; Pushko P; Smith GE; Tumpey TM
    Vaccine; 2015 Apr; 33(18):2152-8. PubMed ID: 25772674
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human anti-N1 monoclonal antibodies elicited by pandemic H1N1 virus infection broadly inhibit HxN1 viruses in vitro and in vivo.
    Hansen L; McMahon M; Turner HL; Zhu X; Turner JS; Ozorowski G; Stadlbauer D; Vahokoski J; Schmitz AJ; Rizk AA; Alsoussi WB; Strohmeier S; Yu W; Choreño-Parra JA; Jiménez-Alvarez L; Cruz-Lagunas A; Zúñiga J; Mudd PA; Cox RJ; Wilson IA; Ward AB; Ellebedy AH; Krammer F
    Immunity; 2023 Aug; 56(8):1927-1938.e8. PubMed ID: 37506693
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B viruses.
    Shen C; Chen J; Li R; Zhang M; Wang G; Stegalkina S; Zhang L; Chen J; Cao J; Bi X; Anderson SF; Alefantis T; Zhang M; Cai X; Yang K; Zheng Q; Fang M; Yu H; Luo W; Zheng Z; Yuan Q; Zhang J; Wai-Kuo Shih J; Kleanthous H; Chen H; Chen Y; Xia N
    Sci Transl Med; 2017 Oct; 9(412):. PubMed ID: 29046433
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of substitutions in the neuraminidase of A(H7N9) influenza viruses selected following serial passage in the presence of different neuraminidase inhibitors.
    Farrukee R; Butler J; Reading PC; Hurt AC
    Antiviral Res; 2019 Aug; 168():68-75. PubMed ID: 31132385
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice.
    Wohlbold TJ; Nachbagauer R; Xu H; Tan GS; Hirsh A; Brokstad KA; Cox RJ; Palese P; Krammer F
    mBio; 2015 Mar; 6(2):e02556. PubMed ID: 25759506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.